Skin
Psoriasis
A chronic immune-mediated skin disease: cytokines drive keratinocytes to turn over in days instead of a month, building thick, silvery, scaly plaques.
Causes et facteurs de risque
- HLA-Cw*0602 in about two thirds
- T cells and dendritic cells release TNF, IL-12, IL-17 and interferon-γ, driving keratinocyte proliferation
Aspect macroscopique
- Thick, silvery, scaling plaques over bony prominences, the scalp, genitalia and hands.
- Nail pitting and onycholysis in a third.
Au microscope
- Elongated rete ridges, thinned stratum granulosum and parakeratosis.
- Neutrophil collections in the upper epidermis.
- Capillaries close to the surface: lifting a scale gives pinpoint bleeding (Auspitz sign).
Évolution
- Immune cells in the skin release cytokines.
- Keratinocytes cross the epidermis in about 4 days instead of a month.
- Scales build up into plaques.
Complications
- Psoriatic arthritis, spondylitis
- Erythroderma and pustular psoriasis
- Affects 1–2% of people
Examens complémentaires
- Clinical examination
- Usually enough: sharply demarcated red plaques with silvery scale, and nail pitting.
- Skin biopsy
- When in doubt: thickened epidermis, parakeratosis, a thin granular layer and neutrophil microabscesses.
- Joint radiographs and rheumatoid factor
- In psoriatic arthritis: erosions with a negative rheumatoid factor.
Traitement médicamenteux
- Systemic corticosteroids (glucocorticoids): Powerful anti-inflammatory and immunosuppressive hormones acting on nuclear receptors: used for flares of inflammatory bowel disease, asthma attacks, brain-tumour oedema and many other conditions, at the price of wide-ranging adverse effects.
- TNF-α inhibitors: Monoclonal antibodies and fusion proteins that neutralise tumour necrosis factor-α, a key inflammatory cytokine; used in moderate to severe Crohn disease, ulcerative colitis, psoriasis and inflammatory arthritis.
- Topical vitamin D analogues (calcipotriol): Creams and ointments that act on vitamin D receptors in keratinocytes, slowing their proliferation and normalising their maturation; a first-line topical treatment for plaque psoriasis, often combined with a corticosteroid.
- Methotrexate (antifolate): A folic acid antagonist that inhibits dihydrofolate reductase: in high doses a cytotoxic drug for osteosarcoma and leukaemias; in low weekly doses an immunosuppressant for psoriasis, rheumatoid arthritis and Crohn disease.
Médicaments à éviter ou à utiliser avec précaution
- Systemic corticosteroids (glucocorticoids) (Avec précaution): Stopping systemic steroids can provoke a severe flare (pustular psoriasis); topical steroids are used instead.
- Immune checkpoint inhibitors (Avec précaution): It can flare.
Rédigé d’après
- Robbins and Cotran Atlas of Pathology, 3rd ed., Ch. 16, The Skin, pp. 429–430, figs 16-60 to 16-62
Ressource pédagogique. Ne constitue pas un avis, un diagnostic ou un traitement médical.